NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tesamorelin from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it.

Test my supply
+18 more ↓
41%
Finnrick rating
#98 of 114 Tesamorelin vendors
7 of 19 classifiable tests passed
natural 37% · customers 4.8★ (9)
methodology · Purity focus
Finnrick analysis · Tesamorelin

Tianjin Ruiwang's Tesamorelin record is dragged down by repeated purity misses and multiple identity failures. The spring pass streak reversed in later testing, including Aug and Nov identity failures, so batch-level details matter.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Ruiwang New Material Technology Co

Corporate records split Ruiwang between a dormant UK company and a cancelled Chinese entity, leaving the current seller unresolved. The report follows dead domains, WhatsApp routes and unbatched COA evidence to assess authentication and traceability.

41 pages6 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
85%
22
2
Retatrutide
$0.73
77%
67
3
Tirzepatide
$0.47
74%
34
4
5-Amino-1MQ
$0.30
65%
4
5
Ipamorelin
$0.77
65%
5
7
PT-141
$0.55
60%
3
8
Cagrilintide
$2.20
51%
3
9
BPC-157
$0.90
49%
14
10
Tesamorelinselected
$2.05
41%
19
11
NAD+
$0.01
32%
4
12
TB-500
$1.32
28%
8
13
CJC-IPA
$1.00
-
0
15
Glutathione
$0.01
-
0
16
hCG
-
-
0
17
Kisspeptin
$1.12
-
0
18
KPV
$0.77
-
0
19
Melanotan I
$0.40
-
0
20
MOTS-c
$0.66
-
0
21
Oxytocin
$1.45
-
0
22
Selank
-
-
0
23
Semax
$0.60
-
0
26
Wolverine
$0.99
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%9 Sep 2025: 19%17 Nov 2025: 23%24 Nov 2025: 22%9 Jan 2026: 23%15 Jan 2026: 21%15 Jan 2026: 25%4 Feb 2026: 26%20 Feb 2026: 27%6 Mar 2026: 28%21 Apr 2026: 33%21 Apr 2026: 36%28 Apr 2026: 39%28 Apr 2026: 42%6 May 2026: 45%12 Jun 2026: 44%21 Jul 2026: 46%12 Aug 2026: 44%13 Aug 2026: 42%2 Nov 2026: 41%15 Nov 2026: current 41%19%26%41%Sep 25Nov 26
Showing Tesamorelin tests only
Peptide testing

Ordered Tesamorelin from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it.

Test my supply
Tianjin Ruiwang New Material Technology Co Tesamorelin test history
COA-backed lab tests
1-10 of 19

About Tianjin Ruiwang New Material Technology Co test results from Finnrick

Tianjin Ruiwang New Material Technology Co is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 188 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Ruiwang New Material Technology Co peptides in this dataset are 5-Amino-1MQ (4 tests), BPC-157 (14 tests) and Cagrilintide (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 188 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Tesamorelin from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it.

Test my supply